StemCells: Press Releases

News > Press Releases

Date	Title (click to view the full text)
5/12/2008	StemCells Files Second Suit Against Neuralstem to Protect Intellectual Property
5/9/2008	StemCells, Inc. Supports National Neurotechnology Initiative Act
5/6/2008	StemCells Announces 2008 First Quarter Results
4/23/2008	StemCells, Inc. Granted Key U.S. Patent Covering Composition of Neural Stem Cells Derived From Any Tissue Source, Including Embryonic
4/15/2008	U.S. Patent Office Upholds StemCells, Inc.'s Patents In Reexamination Decisions
3/14/2008	StemCells Announces 2007 Fourth Quarter And Year End Results
3/4/2008	StemCells, Inc. Terminates Its Discussions To Acquire Progenitor Cell Therapy, LLC
1/24/2008	StemCells, Inc. Enters Research Collaboration With Casey Eye Institute
1/18/2008	StemCells, Inc. Provides Batten’s Clinical Trial Update
12/3/2007	StemCells, Inc. Exploring Acquisition of Progenitor Cell Therapy, LLC
11/30/2007	First Patient Completes StemCells, Inc.’s Phase I Clinical Trial
11/05/2007	StemCells Announces Third Quarter 2007 Financial Results
11/01/2007	StemCells, Inc. to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference
9/26/2007	StemCells, Inc. Announces Research Collaboration Focused On Cell-Based Liver Therapy
9/20/2007	StemCells, Inc. to Present at UBS Global Life Sciences Conference
9/17/2007	StemCells to Begin Patent Reexamination Process with U.S. Patent and Trademark Office
7/31/07	StemCells Announces Second Quarter 2007 Financial Results
6/28/07	StemCells, Inc. Agrees to Stay Litigation Against Neuralstem Pending Reexamination of Patents Involved in Lawsuit
6/18/07	StemCells, Inc. Announces Important Milestone in Batten Disease Clinical Trial
6/05/07	StemCells, Inc. Announces Pulblication Describing Non-Invasive Tracking of Human Neural Stem Cells Transplanted In Vivo
5/07/07	StemCells Announces First Quarter 2007 Financial Results
2/28/07	StemCells Announces Fourth Quarter and Year End 2006 Financial Results
1/12/07	StemCells, Inc., Elects Desmond O'Connell to Board of Directors